Your browser doesn't support javascript.
loading
Gemcitabine and cisplatin plus durvalumab with or without tremelimumab in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, single-centre, phase 2 study.
Oh, Do-Youn; Lee, Kyung-Hun; Lee, Dae-Won; Yoon, Jeesun; Kim, Tae-Yong; Bang, Ju-Hee; Nam, Ah-Rong; Oh, Kyoung-Seok; Kim, Jae-Min; Lee, Young; Guthrie, Violeta; McCoon, Patricia; Li, Weimin; Wu, Song; Zhang, Qu; Rebelatto, Marlon C; Kim, Jin Won.
Afiliação
  • Oh DY; Division of Medical Oncology, Seoul National University Hospital, Seoul, South Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea; Seoul National University Graduate School, Seoul, South Korea. Electronic address: ohdoyoun@snu.ac.kr.
  • Lee KH; Division of Medical Oncology, Seoul National University Hospital, Seoul, South Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea.
  • Lee DW; Division of Medical Oncology, Seoul National University Hospital, Seoul, South Korea.
  • Yoon J; Division of Medical Oncology, Seoul National University Hospital, Seoul, South Korea.
  • Kim TY; Division of Medical Oncology, Seoul National University Hospital, Seoul, South Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea.
  • Bang JH; Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea.
  • Nam AR; Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea.
  • Oh KS; Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea.
  • Kim JM; Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea; Seoul National University Graduate School, Seoul, South Korea.
  • Lee Y; AstraZeneca, Gaithersburg, MD, USA.
  • Guthrie V; AstraZeneca, Gaithersburg, MD, USA.
  • McCoon P; AstraZeneca, Gaithersburg, MD, USA.
  • Li W; AstraZeneca, Gaithersburg, MD, USA.
  • Wu S; AstraZeneca, Gaithersburg, MD, USA.
  • Zhang Q; AstraZeneca, Gaithersburg, MD, USA.
  • Rebelatto MC; AstraZeneca, Gaithersburg, MD, USA.
  • Kim JW; Seoul National University Bundang Hospital, Seongnam, South Korea.
Lancet Gastroenterol Hepatol ; 7(6): 522-532, 2022 06.
Article em En | MEDLINE | ID: mdl-35278356
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias do Sistema Biliar / Cisplatino Tipo de estudo: Guideline Limite: Adult / Humans Idioma: En Revista: Lancet Gastroenterol Hepatol Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias do Sistema Biliar / Cisplatino Tipo de estudo: Guideline Limite: Adult / Humans Idioma: En Revista: Lancet Gastroenterol Hepatol Ano de publicação: 2022 Tipo de documento: Article